Antiepileptic drugs in neuroprotection

Bibliography

• SCOTT DF: The history of epileptic therapy. In: The Panthenon Publishing group. NY, USA (1993).
   Google Scholar
• LOPES DA SILVA F, POST RM: Evaluation and prediction of effects of antiepileptic drugs in a variety of other CNS disorders. Epilepsy Res. (2002) 50:191–193.
   PubMedGoogle Scholar
• MELDRUM BS: Implications for neuroprotective treatments.Frog. Brant Res. (2002) 135:487–495.
   PubMedGoogle Scholar
• ••An interesting review about variousneuroprotective strategies in neurodegeneration.
   Google Scholar
• TROJANAR MK, MALEK R, CHROSCINSKA M, NOWAK S, BLASZCZYK B, CRUCZWAR SJ: Neuroprotective effects of antiepileptic drugs. Poi Pharmacol. (2002) 54:557–566.
   Google Scholar
• PITKANEN A: Drug-mediated neuroprotection and antiepileptogenesis: animal data. Neurology (2002) 59\(Suppl. 5):S27–S33.
   Google Scholar
• LEKER RR, NEUFELD MY: Antiepileptic drugs as possible neuroprotectants in cerebral ischemia. Brant Res. Brant Res. Rev (2003) 42(3):187–203.
   PubMedGoogle Scholar
• ••Summarises the experimental dataavailable about the neuroprotective effects of AEDs in stroke.
   Google Scholar
• CALABRESI P, CUPINI LM, CENTONZE D, PISANI F, BERNARDI G: Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia. Ann. Neurol. (2003) 53(6):693–702.
   PubMed Web of Science ®Google Scholar
• ••Surnrnarises the experimental dataavailable about the neuroprotective effects of AEDs in stroke.
   Google Scholar
• KITO M, MAEHARA M,WATANABE K: Antiepileptic drugs: calcium current interaction in cultured human neuroblastoma cells. Seizure (1994) 3:141–149.
   PubMedGoogle Scholar
• STEFANI A, CALABRESI P, PISANI A, MERCURI NB, SINISCALCHI A, BERNARDI G: Felbamate inhibits dihydropyridine-sensitive calcium channels in central neurons. Pharmacol. Exp. Therap. (1996) 277:121–127.
   PubMedGoogle Scholar
• ZHANG X, VELUMIAN AA, JONES OT, CARLEN PL: Modulation of high voltage-activated calcium channels in dentategranule cells by topiramate.Epilepsia (2000) 41\(Suppl. 1):S52–S60.
   Google Scholar
• FINK K, DOLLEY DJ, MEDER WP et al:Inhibition of neuronal Ca2+influx by gabapentin and pregabalin in the human cortex. Neuropharmacology (2002) 42:229–236.
   PubMed Web of Science ®Google Scholar
• CALABRESI P, DEMURTAS M, STEFANI A et al.: Action of GP 47779, active metabolite of oxcarbazepine, on the corticostriatal system: I. Modulation of corticostriatal synaptic transmission. Epilepsia (1995) 36:990–996.
   Google Scholar
• DELORENZO RJ: Calmodulin inneurotransmitter release and synaptic function. Fed. Proc. (1982) 41:2275.
   Google Scholar
• GAO XM, MARGOLIS RL, LEEDS P, HOUGH C, POST RM, CHUANG DM. Carbamazepine induction of apoptosis in cultured cerebellar neurons: effects of N-methyl-D-aspartate, aurintricarboxylic acid and cycloheximide. Brant Res. (1995) 703(1-2):63–71.
   PubMed Web of Science ®Google Scholar
• NONAKA S, KATSUBE N,CHUANG DM: Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine. Pharmacol. Exp. Thec (1998) 286(1):539–47.
   PubMed Web of Science ®Google Scholar
• AMBROSIO AF, SILVA AP, ARAUJO I et al.: Neurotoxic/neuroprotective profile of carbamazepine, oxcarbazepine and two new putative antiepileptic drugs, BIA 2-093 and BIA 2-024. Eur.j Pharmacol. (2000) 406:191–201.
   PubMed Web of Science ®Google Scholar
• LI X, BIJUR GN, JOPE RS: Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection. Bipolar Disord. (2002) 4:137–144.
   PubMed Web of Science ®Google Scholar
• MAI L, JOPE RS, LI X: BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents. Neurochem. (2002) 82:75–83.
   PubMed Web of Science ®Google Scholar
• SEYFRIED J, EVERT BO,RUNDFELDT C et al: Flupirtine and retigabine prevent L-glutamate toxicity in rat pheochromocytoma PC 12 cells. Eur. Pharmacol. (2000) 400(2–3):155-166.
   Google Scholar
• LI X, KETTER TA, FRYE MA:Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders? I Affect, Disord.(2002) 69:1–14.
   Google Scholar
• VAJDA FJ: Valproate and neuroprotection. Clin. Neurosci. (2002) 9:508–514.
   Google Scholar
• MORA A, GONZALEZ-POLO RA, FUENTES JM, SOLER G, CENTENO F: Different mechanisms of protection against apoptosis by valproate and Li+. Eur: Biochem. (1999) 266:886–891.
   PubMedGoogle Scholar
• LI R, EL-MALLAHK RS: A novel evidenceof different mechanisms of lithium and valproate neuroprotective action on human SY5Y neuroblastoma cells: caspase-3 dependency. NeuroscL Lett. (2000) 294:147–150.
   PubMedGoogle Scholar
• CHEN G, YUAN PX, JIANG YM, HUANG LD, MANJI HK: Valproate robustly enhances AP-1 mediated gene expression. Mol. Brant. Res. (1999) 64:52–58.
   PubMedGoogle Scholar
• CHEN G, ZENG WZ, YUAN PX et al:The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bc1-2 in the CNS.Neurochem. (1999) 72:879–882.
   PubMed Web of Science ®Google Scholar
• WANG JF, AZZAM JE, YOUNG LT: Valproate inhibits oxidative damage to lipid and protein in primary cultured rat cerebrocortical cells. Neuroscience (2003) 116:485–489.
   PubMed Web of Science ®Google Scholar
• FUKUMOTO T, MORINOBU S, OKAMOTO Y, KAGAYA A,YAMAWAKI S: Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (2001) 158:100–106.
   PubMed Web of Science ®Google Scholar
• YUAN PX, HUANG LD, JIANG YM, GUTKIND JS, MANJI HK, CHEN G: The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. j Biol. Chem. (2001) 276:31674–31683.
   PubMed Web of Science ®Google Scholar
• MANJI HK, CHEN G: PKC, MAP kinases and the bc1-2 family of proteins as long-term targets for mood stabilizers.Mol. Psychiatry (2002) 7\(Suppl. 1):546–556.
   Google Scholar
• JEONG MR, HASHIMOTO R,SENATOROV VV: Valpmic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition. FEBS Lett. (2003) 542:74–78.
   PubMed Web of Science ®Google Scholar
• HENNION JP, EL-MASRI MA,HUFF MO, EL-MAILAKH RS: Evaluation of neuroprotection by lithium and valproic acid against ouabain-induced cell damage. Bipolar Disord. (2002) 4(3):201–206.
   PubMedGoogle Scholar
• SCHAUWECKER PE: Complications associated with genetic background effects in models of experimental epilepsy. Frog. Brain Res. (2002) 135:139–148.
   PubMedGoogle Scholar
• •An excellent review about the contribution of genetic background on suspectibility to neurodegeneration induced by prolonged seizures.
   Google Scholar
• TEMKIN NR: Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia (2001) 42:515–524.
   PubMed Web of Science ®Google Scholar
• ••Summarises the data available about theantiepileptogenic effects of AEDs in human TBI.
   Google Scholar
• SALMENPERA T, KONONEN M, ROBERTS N, VANNINEN R, PITKANEN A, KALVIAINEN R: Association of imaging findings with clinical outcome. Epilepsia (2002) 43\(Supp1.7):304–305.
   Google Scholar
• SULZBACHER S, FARWELL JR, TEMKIN N, LU AS, HIRTZ DG: Late cognitive effects of early treatment with phenobarbital. Clin. Pediatr. (1999) 38:387–394.
   PubMed Web of Science ®Google Scholar
• CAMFIELD P, CAMFIELD C, DOOLEY J, SMITH E, GARNER B: A randomized study of carbamazepine versus no medication after a first unprovoked seizure in childhood. Neurology (1989) 39:851–852.
   PubMed Web of Science ®Google Scholar
• HIRTZ D, BERG A, BETTIS D et al.: Practice parameter: treatment of child with a first unprovoked seizure. Practice parameter: treatment of the child with a first unprovoked seizure: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology (2003) 60:166–175.
   Google Scholar
• YOUNG B, RAPP RP, NORTON JA, HAACK D, TIBBS PA, BEAN JR: Failure of prophylactically administered phenytoin to prevent late posttraumatic seizures.Neurasurg. (1983) 58:236–241.
   PubMed Web of Science ®Google Scholar
• RATAUD J, DEBARNOT F, MARY V, PRATT J, STUTZMANN J: Comparative study of voltage-sensitive sodium channel blockers in focal ischemia and electric convulsions in rodents. Neurasci. Lett. (1994) 172:19–23.
   PubMed Web of Science ®Google Scholar
• MINATO H, KIKUTA C, FUJITANI B, MASUDA Y: Protective effect of zonisamide, an antiepileptic drug, against transient focal cerebral ischemia with middle cerebral artery occlusion-reperfusion in rats. Epilepsia (1997) 38:975–980.
   PubMed Web of Science ®Google Scholar
• CAPELLA HM, LEMOS T: Effect on epileptogenesis of carbamazepine treatment during the silent period of the pilocarpinemodel of epilepsy. Epilepsia (2002) 43\(Suppl. 5):S110–S111.
   Google Scholar
• SCHMUTZ M, KLEBS K, BALTZER V: Inhibition or enhancement kindling evolution by antiepileptics. j Neural. Transm. (1988) 72:245–257.
   PubMedGoogle Scholar
• SILVER JM, SHIN C, MCNAMARA JO: Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilepsy. Ann. Neural. (1991) 29:356–363.
   PubMedGoogle Scholar
• EBERT U, REISSMOLLER E,LOSCHER W: The new antiepileptic drugs lamotrigine and felbamate are effective in phenytoin-resistant kindled rats. Neurapharmacalogy (2000) 39:1893–1903.
   PubMedGoogle Scholar
• VVEISS SRB, POST RM:Carbamazepine and carbamazepine-10,11-epoxide inhibit amygdala-kindled seizures in the rat but do not block their development. Clin. Neurapharmacal. (1987) 10:272–279.
   PubMedGoogle Scholar
• SATO H, MORIMOTO K, YAMAMOTO Y, WATANABE T, SUWAKI H: Anticonvulsant effect of tiagabine, a new antiepileptic drug: the profile of action in the rat kindling model of epilepsy. Epilepsia (1996) 37\(Suppl. 3):S110–S111.
   Google Scholar
• NISSINEN JPT, PITKANEN A: An animal model with spontaneus seizures: a new tool for testing the effects of antiepileptic compounds. Epilepsia (2000b)41 (Suppl. Florence):S136.
   Google Scholar
• LAHTINEN H, YLINEN A, LUKKARINEN U, SIRVIO MIETTINEN R, RIEKKINEN P: Failure of carbamazepine to prevent behavioural and histopathological sequels of experimentally induced status epilepticus. Eur. Pharmacy]. (1996) 297:213–218.
   PubMedGoogle Scholar
• PITKANEN A, TUUNANEN HALONEN T: Vigabatrin and carbamazepine have different efficacies in the prevention of status epilepticus induced neuronal damage in the hippocampus and amygdala. Epilepsy Res. (1996) 24:29–45.
   PubMedGoogle Scholar
• HALONEN T, NISSINEN J,PITKANEN A: Neuroprotective effect of remacemide hydrochloride in a perforant pathway stimulation model of status epilepticus in the rat. Epilepsy Res.(1999) 34:251–269.
   PubMed Web of Science ®Google Scholar
• HALONEN T, NISSINEN J,PITKANEN A: Effect of lamotrigine treatment on status epilepticus-induced neuronal damage and memory impairment in rat. Epilepsy Res. (2001) 46:205–223.
   PubMed Web of Science ®Google Scholar
• VEZZANI A, WU HQ, ANGELICO P, STASI MA, SAMANIN R: Quinolinic acid-induced seizures, but not nerve cell death, are associated with extracellular Ca2' decrease assessed in the hippocampus by brain dialysis. Brain Res. (1988) 454:289–297.
   PubMedGoogle Scholar
• ICHIMARU Y, GOMITA Y,MORIYAMA M: Effects of clobazam on amygdaloid and hippocampal kindled seizures in rats. Pharmacabiadyn. (1987) 10:189–194.
   Google Scholar
• HARRIS QL, LEWIS SJ, YOUNG NA, VAJDA FJ, JARROTT B: Relationship between the dose-response effects of diazepam and clobazam on electroencephalographic parameters and on kindled amygdaloid seizure activity in rats. Clin. Exp. Pharmacy]. Physial. (1988) 15:753–764.
   PubMedGoogle Scholar
• MARCIANI MG, SANTONE G, SANCESARIO G, MASSA R, STANZIONE P, BERNARDI G: Protective effects of clonazepam on ischemic brain damage induced by 10-minute bilateral carotid occlusion in Mongolian gerbils. Funct. Neural (1993) 8:114–119.
   Google Scholar
• VOITS M, FREY HH: Stimulation-dependent effect of antiepileptic drugs in amygdala kindled rats on both seizure score and duration on afterdischarges.Pharmacy]. Tarim]. (1994) 75:54–61.
   Google Scholar
• KUBOVA H, MARES P, VORLICEK J: Stable anticonvulsant action of benzodiazepines during development. Pharm. Pharmacy]. (1993) 45:807–810.
   PubMedGoogle Scholar
• ALBRIGHT PS, BURNHAM WM: Development of a new pharmacological seizure model: effects of anticonvulsants on cortical- and amygdala-kindled seizures in the rat. Epilepsia (1980) 21:681–689.
   PubMed Web of Science ®Google Scholar
• SHOUSE MN, STROH PJ, VREEKEN T: Anticonvulsant drugs selectively affect kindled and penicillin epilepsy, especially during seizure-prone sleep of awakening states in cats. Epilepsia (1989) 30:7–16.
   PubMedGoogle Scholar
• MAZARATI AM, BALDWIN RA, SOFIA RD, WASTERAIN CG: Felbamate in experimental model of status epilepticus. Epilepsia (2000) 41:123–127.
   PubMedGoogle Scholar
• WASTERLAIN CG, ADAMS LM, SCHWARTZ PH, HATTORI H, SOFIA RD, WICHMANN JK: Posthypoidc treatment with felbamate is neuroprotective in a rat model of hypoxia-ischemia. Neurology (1993) 43:2303–2310.
   PubMed Web of Science ®Google Scholar
• BERTORELLI R, SMIRNE S, ADAMI M, DE RINO F, IANNACCONE S: Neuroprotective effects of felbamate on global ischemia in Mongolian gerbils. Pharmacol Res. (1996) 34:59–64.
   PubMedGoogle Scholar
• WASTERLAIN CG, ADAMS LM, WICHMANN JK, SOFIA RD: Felbamate protects CA1 neurons from apoptosis in a gerbil model of global ischemia.Stroke (1996) 27:1236–1240.
   PubMedGoogle Scholar
• SHUAIB A, WAQAAR T, IJAZ MS, KANTHAN R, WISHART T, HOWLETT W: Neuroprotection with felbamate: a 7- and 28-day study in transient forebrain ischemia in gerbils. Brant Res. (1996a) 727:65–70.
   PubMedGoogle Scholar
• CHRONOPOULOS A, STAFSTROM C, THURBER S, HYDE P, MIKATI M, HOLMES GL: Neuroprotective effect of felbamate after kainic acid-induced status epilepticus. Epilepsia (1993) 34(2):359–366.
   PubMedGoogle Scholar
• MAZARATI AM, SOFIA RD, WASTERLAIN CG: Anticonvulsant andantiepileptogenic effects of fluorofelbamate in experimental status epilepticus.Seizure (2002) 11:423–430.
   PubMedGoogle Scholar
• SOFIA RD: Felbamate - mechanism of action. In: Antiepileptic Drugs (4th edit). Levy RH, Mattson RH, Meldrum BS (Eds), Raven Press, NY, USA (1995):791.
   Google Scholar
• WHITE HS, WOLF HH,SWINYARD EA, SKEEN GA,SOFIA RD: A neuropharmacologicalevaluation of felbamate as a novel anticonvulsant. Epilepsia (1992) 33:564–572.
   PubMed Web of Science ®Google Scholar
• CILIO MR, BOLANOS AR, LIU Z et al: Anticonvulsant action and long-term effects of gabapentin in the immature brain.Neuropharmacology (2001) 40:139–147.
   PubMed Web of Science ®Google Scholar
• DALBY NO, NIELSEN EB: Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin. Epilepsy Res. (1997b) 28:63–72.
   PubMed Web of Science ®Google Scholar
• MAJ R, FARIELLO RG, PEVARELLO P, VARASI M, MCARTHUR RA,SALVATI P: Anticonvulsant activity of PNU-151774E in the amygdala kindled model of complex partial seizures.Epilepsia (1999) 40:1523–1528.
   PubMed Web of Science ®Google Scholar
• LADO FA, SPERBER EF, MOSHE SL: Anticonvulsant efficacy of gabapentin on kindling in the immature brain.Epilepsia (2001) 42:458–463.
   PubMedGoogle Scholar
• ZUCCHINI S, BUZZI A, BERGAMASCHI M, PIETRA C, VILLETTI G, SIMONATO M:Neuroprotective activity of CHF3381, a putative N-methyl-D-aspartate receptor antagonist. Neuroreport (2002) 13:2071–2074.
   PubMedGoogle Scholar
• SHUAIB A, MAHMOOD RH,WISHART T et al.: Neuroprotective effects of lamotrigine in global ischemia in gerbils. A histological, in vivo microdialysis and behavioral study. Brant Res. (1995) 702:199–206.
   Google Scholar
• WIARD RP, DICKERSON MC, BEEK 0, NORTON R, COOPER BR: Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia.Stroke (1995) 26:466–472.
   PubMed Web of Science ®Google Scholar
• SMITH SE, MELDRUM BS: Cerebroprotective effect of lamotrigine after focal ischemia in rats. Stroke (1995) 26:117–122.
   PubMed Web of Science ®Google Scholar
• TRAYSTMAN RJ, KLAUS JA,DEVRIES AC, SHAIVITZ AB,HURN PD: Anticonvulsant lamotrigine administered on reperfusion fails to improve experimental stroke outcomes.Stroke (2001) 32:783–787.
   PubMed Web of Science ®Google Scholar
• CRUMRINE RC, BERGSTRAND K, COOPER AT, FAISON WL,COOPER BR: Lamotrigine protects hippocampal CA1 neurons from ischemic damage after cardiac arrest.Stroke (1997) 28:2230–2237.
   PubMed Web of Science ®Google Scholar
• KANTHASAMY AG, TITH T,NGUYEN B, IRAN A, TRUONG DD: Antimyoclonic and neuroprotective effects of lamotrigine in an animal model of cardiac arrest. Restor: Neurol Neurosci. (1999) 15:45–56.
   PubMedGoogle Scholar
• YI Y-H, GUO W-C, LIAO W-P: Neuroprotective effects of lamotrigine on hypoxic-ischemic encephalopathy in neonatal rats: relationship with administration time.Epilepsia (2003) 44\(Suppl. 8):5177.
   Google Scholar
• POSTMA T, KRUPP E, LI X, POST RM, WEISS SRB: Lamotrigine treatment during amygdala-kindled seizure development fails to inhibit seizures and diminishes subsequent anticonvulsant efficacy.Epilepsia (2000) 41:1514–1521.
   PubMed Web of Science ®Google Scholar
• STRATTON SC, LARGE CH, COX B, DAVIES G, HAGAN RM: Effects of lamotrigine and levetiracetam on seizure development in a rat amygdala kindling model. Epilepsy Res. (2003) 53:95–106.
   PubMedGoogle Scholar
• O'DONNELL RA, MILLER AA: The effect of lamotrigine upon development ofcortical kindled seizures in the rat.Neuropharmacology (1991) 30:253–258.
   PubMed Web of Science ®Google Scholar
• OTSUKI K, MORIMOTO K, SATO K, YAMADA N, KURODA S: Effects of lamotrigine and conventional antiepileptic drugs on amygdala- and hippocampal-kindled seizures in rats. Epilepsy Res. (1998) 31:101–112.
   PubMed Web of Science ®Google Scholar
• KLITGAARD HV, MATAGNE AC, VANNESTE-GOEMAERE J et al.:Effects of prolonged administration of levetiracetam on pilocarpine-induced epileptogenesis in rat. Epilepsia (2001) 42\(Suppl. 7):5114–5115.
   Google Scholar
• MAZARATI AM, BALDWIN RA, KLITGAARD H, MATAGNE A, WASTERLAIN CG: Treatment withlevetiracetam during the latent period afterexperimental status epilepticus reduces chronic spontaneous recurrent seizures.Epilepsia (2003) 44\(Suppl. 9):223.
   Google Scholar
• SASA M, YAN H, NAGAYAMA T, SERIKAWA T: Anti-epileptogenicproperties of levetiracetam in the spontaneously epileptic rat (SER)Epilepsia (2003) 44\(Suppl. 8):175.
   Google Scholar
• LOSCHER W, HONACK D,RUNDFELDT C: Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy. Pharmacol Exp. Ther: (1998) 284:474–479.
   Google Scholar
• GLIEN M, BRANDT C, POTSCHKA H, LOSCHER W: Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy.Epilepsia (2002) 43:350–357.
   PubMedGoogle Scholar
• ALLEGRINI P, SAUER D,SCHMUTZ M: neuroprotective effect of the antiepileptic drug oxcarbazepine (Trileptal (R)) against permanent focal cerebral ischemia following middle cerebral artery occlusion in rats. Epilepsia (2003) 44\(Suppl. 8):177.
   Google Scholar
• SCHMUTZ M, BRUGGER F,GENTSCH C, MCLEAN MJ, OLPE HR:Oxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of action.Epilepsia (1994) 5(Suppl.):S47–S50.
   Google Scholar
• MIKATI MA, HOLMES GL, CHRONOPOULOS A et al.:Phenobarbital modifies seizure-related brain injury in the developing brain.Ann. Neurol (1994) 36:425–433.
   PubMed Web of Science ®Google Scholar
• BOLANOS AR, SARKISIAN M, YANG Y et al.: Comparison of valproate andphenobarbital treatment after status epilepticus in rats. Neurology (1998) 51:41–48.
   PubMed Web of Science ®Google Scholar
• SUTULA T, CAVAZOS J, GOLARAI G: Alteration of long-lasting structural and functional effects of kainic acid in the hippocampus by brief treatment with phenobarbital. NeuroscL (1992) 12:4173–4187.
   PubMedGoogle Scholar
• PRASAD A, WILLIAMSON JM, BERTRAM EH: Phenobarbital and MK-801, but not phenytoin, improve the long-term outcome of status epilepticus. Ann. Neurol (2002) 51:175–181.
   PubMedGoogle Scholar
• BRANDT C, VOLK HA, LOSCHER W: Selection of pharmacoresistant rats from a chronic epilepsy model by treatment with phenobarbital. Epilepsia (2003) 44 (Suppl. 9):197.
   Google Scholar
• FULLER TA, OLNEY JW: Only certain anticonvulsants protect against kainate neurotoxicity. Neurobehav. Toxicol Teratol (1981) 3:355–361.
   PubMedGoogle Scholar
• AULT B, GRUENTHAL M,AMSTRONG DR, NADLER JV: Efficacy of baclofen and phenobarbital against the kainic acid limbic seizure-brain damage syndrome." Pharmacol Exp. Ther. (1986) 239:612–617.
   PubMedGoogle Scholar
• HAYAKAWA T, HAMADA Y, MAIHARA T, HATTORI H, MIKAWA H: Phenytoin reduces neonatal hypoxic-ischemic brain damage in rats.Life Sci. (1994) 54:387–392
   PubMedGoogle Scholar
• EDMONDS HL Jr JIANG YD,ZHANG PY, SHANK R: Topiramate as a neuroprotectant in a rat model of globalischemia-induced neurodegeneration.Life Sci. (2001) 69:2265–2277.
   PubMedGoogle Scholar
• CHAN SA, REID KH, SCHURR A, MILLER JJ, IYER V, ISENG MT: Fosphenytoin reduces hippocampal neuronal damage in rat following transient global ischemia. Acta Neurochic (1998) 140:175–180.
   PubMed Web of Science ®Google Scholar
• HERGUIDO MJ, CARCELLER F, RODA JM, AVENDANO C: Hippocampal cell loss in transient global cerebral ischemia in rats: a critical assessment. Neuroscience (1999) 93:71–80.
   PubMedGoogle Scholar
• MORIMOTO K, SATO H, SATO K, SATO S, YAMADA N: BW1003C87, phenytoin and carbamazepine elevate seizure threshold in the rat amygdala-kindling model of epilepsy. Eur. Pharmacol (1997) 339:11–15.
   PubMedGoogle Scholar
• ANDRE V, RIGOULOT MA,KONING E, FERRANDON A,NEHLIG A: Long-term pregabalin treatment protects basal cortices and delays the occurrence of spontaneous seizures in the lithium-pilocarpine model in the rat. Epilepsia (2003) 44:893–903.
   PubMed Web of Science ®Google Scholar
• LOSCHER W, HONACK D: Comparison of the anticonvulsant efficacy of primidone and phenobarbital during chronic treatment of amygdala-kindled rats. Ear: J. Pharmacol (1989) 162:309–322.
   PubMedGoogle Scholar
• EBERT U, BRANDT C, LOSCHER W: Delayed sclerosis, neuroprotection, and limbic epileptogenesis after status epilepticus in the rat. Epilepsia (2002) 43\(Suppl. 5):86–95.
   Google Scholar
• TOBER C, ROSTOCK A,RUNDFELDT C, BARTSCH R: D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures. Eur. Pharmacol (1996) 303(3):163–169.
   PubMedGoogle Scholar
• BELAYEV L, ALONSO OF, LIU Y et al: Talampanel, a novel noncompetitive AMPA antagonist, is neuroprotective after traumatic brain injury in rats.Neurotrauma (2001) 18:1031–1038.
   PubMed Web of Science ®Google Scholar
• JOHANSEN FE DIEMER DH: Enhancement of GABA neurotransmission after cerebral ischemia in the rat reduces loss of hippocampal CA1 pyramidal cells. Acta Neurol Scand. (1991) 84:1–6.
   PubMedGoogle Scholar
• INGLEFIELD JR, PERRY JM,SCHWARTZ RD: Postischemic inhibition of GABA reuptake by tiagabine slows neuronal death in the gerbil hippocampus. Hippocampus (1995) 5:460–468.
   PubMedGoogle Scholar
• XU WC, YI Y, QIU L, SHUAIB A: Neuroprotective activity of tiagabine in a focal embolic model of cerebral ischemia. Brain Res. (2000) 874:75–77.
   PubMedGoogle Scholar
• YANG Y, LI Q, WANG CX, JEERAKATHIL T, SHUAIB A: Dose-dependent neuroprotection with tiagabine in a focal cerebral ischemia model in rat. Neuroreport (2000a) 11:2307–2311.
   PubMedGoogle Scholar
• IQBAL S, BAZIANY A, GORDON S et al.: Neuroprotective effect of tiagabine in transient forebrain global ischemia: an in vivo microdialysis, behavioral, and histological study. Brant Res. (2002) 946:162–170.
   PubMed Web of Science ®Google Scholar
• DALBY NO, NIELSEN EB: Tiagabine exerts an anti-epileptogenic effect in amygdala kindling epileptogenesis in the rat. Neurosci. Lett. (1997a) 229:135–137.
   PubMedGoogle Scholar
• HALONEN T, NISSINEN J, JANSEN JA, PITKANEN A: Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticus.Eur.j Pharmacol (1996) 299:69–81.
   PubMedGoogle Scholar
• NIEBAUER M, GRUENTHAL M: Topiramate reduces neuronal injury after experimental status epilepticus. Brant Res. (1999) 837:263–269.
   PubMed Web of Science ®Google Scholar
• RIGOULOT MA, KONING E, FERRANDON A, NEHLIG A: Neuroprotective effect of topiramate in the lithium- pilocarpine model of epilepsy. Pharmacol Exp. Ther: (2003) 308(2):787–795.
   PubMedGoogle Scholar
• CHA BH, SILVEIRA DC, LIU X, HU Y, HOLMES GL: Effect of topiramate following recurrent and prolonged seizures during early development. Epilepsy Res. (2002) 51:217–232.
   PubMed Web of Science ®Google Scholar
• YANG Y, SHUAIB A, LI Q, SIDDIQUI MS: Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization. Brant Res. (1998) 804:169–176.
   PubMed Web of Science ®Google Scholar
• YANG Y, LI Q, MIYASHITA H, HOWLETT W, SIDDIQUI M, SHUAIB A: Usefulness of postischemic thrombolysis with of without neuroprotection in a focal embolic model of cerebral ischemia.Neurosurg. (2000) 92:841–847.
   Google Scholar
• LEE SR, KIM SP, KIM JE: Protective effect of topiramate against hippocampal neuronal damage after global ischemia in the gerbils. Neurosci. Lett. (2000b) 281:183–186.
   PubMed Web of Science ®Google Scholar
• YANG Y, LI Q, SHUAIB A: Enhanced neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate. Neuropharmacology (2000) 39:881–888.
   PubMedGoogle Scholar
• SUCHOMELOVA L, BALDWIN RA, MAZARATI A, WASTERLAIN CG: Efficacy of toprimate in blocking epileptogenesis after lithium-pilocarpine status epilepticus depends on time of treatment. Epilepsia (2002)43\(Suppl. 7):533–534.
   Google Scholar
• KOH S, JENSEN E: Topiramate blocks perinatal hypoxia-induced seizures in rat pups. Ann. Neurol (2001) 50:366–372.
   PubMedGoogle Scholar
• AMANO K, HAMADA K, YAGI K, SEINO M: Antiepileptic effects of topiramate on amygdaloid kindling in rats. Epilepsy Res. (1998) 31:123–128.
   PubMedGoogle Scholar
• NAKAMURA F, HIYOSHI T, KUDO T, YAGI K, SEINO M: Anticonvulsant effect of topiramate on amygdaloid kindled seizures in cats. fpn. Psychiatry Nemo]. (1993) 47:349–395.
   Google Scholar
• WAUQUIER A, ZHOU S: Topiramate: a potent anticonvulsant in the amygdala-kindled rat. Epilepsy Res. (1996) 24:73–77.
   PubMed Web of Science ®Google Scholar
• LOSCHER W: Valproic acid. Handbook Exp. Pharmacol (1985) 74:507–536.
   Google Scholar
• POLASEK R, KUBOVA H, SLAMBEROVA R, MARES P, VORLICEK J: Suppression of cortical epileptic afterdischarges in developing rats by anticonvulsants increasing GABAergic inhibiton. Epilepsy Res. (1996) 25:177–184.
   PubMedGoogle Scholar
• JOLKKONEN J, HALONEN T, JOLKKONEN E, NISSINEN J, PITKANEN A: Seizure-induced damage to the hippocampus is prevented by modulation of the GABAergic system. NeuroReport (1996) 7:2031–2035.
   PubMedGoogle Scholar
• PITKANEN A, NISSINEN JOLKKONEN E, TUUNANEN J, HALONEN T: Effects of vigabatrin treatment on status epilepticus-induced neuronal damage and mossy fiber sprouting in the rat hippocampus.Epilepsy Res. (1999) 33:67–85.
   PubMedGoogle Scholar
• HALONEN T, NISSINEN J,PITKANEN A: Chronic elevation of brain GABA levels beginning two days after status epilepticus does not prevent epileptogenesis in rats. Neuropharmacology (2001) 40:536–550.
   PubMed Web of Science ®Google Scholar
• LOTHMAN EW, WILLIAMSON JM, GOOSENS KA, BERTRAM EH: Vigabatrin improves behavioral outcome in a rat model of mesial temporal lobe epilepsy. American Epilepsy Socieo, Meeting,San Fransisco, USA (1996).
   Google Scholar
• ANDRE V, FERRANDON A,MARESCAUX C, NEHLIG A: Vigabatrin protects against hippocampal damage but is not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy. Epilepsy Res. (2001) 47:99–117.
   PubMed Web of Science ®Google Scholar
• SHUAIB A, MURABIT MA,KANTHAN R, HOWLETT W, WISHART T: The neuroprotective effects of gamma-vinyl GABA in transient global ischemia: a morphological study with early and delayed evaluations. NeuroscL Lett. (1996b) 204:1–4.
   PubMed Web of Science ®Google Scholar
• SHIN C, RIGSBEE LC,MCNAMARA JO: Anti-seizure and anti-epileptogenic effect of 7-vinyly-aminobutyric acid in amygdaloid kindling. Brain Res. (1986) 398:370–374
   PubMed Web of Science ®Google Scholar
• LOSCHER W, JACKEL R, MULLER F: Anticonvulsant and proconvulsant effects of inhibitors of GABA degradation in the amygdala-kindling model. Ear.Pharmacol (1989) 163:1–14.
   PubMedGoogle Scholar
• YLINEN AMA, MIETTINEN R, PITKANEN A, GULYAS Al,FREUND TF, RIEKKINEN PJ: Enhanced GABAergic inhibition preserves hippocampal structure and function in a model of epilepsy. Proc. Natl. Acad. Sci. (1991) 88:7650–7653.
   PubMedGoogle Scholar
• HALONEN T, MIETTINEN R, TOPPINEN A, TUUNANENJ, KOTTI T, RIEKKINEN P: Vigabatrin protects against kainic acid-induced neuronal damage in the rat hippocampus. Neurosci. Lett. (1995) 195:13–16.
   PubMedGoogle Scholar
• OWEN AJ, IJAZ S, MIYASHITA H, WISHART T, HOWLETT W, SHUAIB A: Zonisamide as a neuroprotective agent in an adult gerbil model of global forebrain ischemia: a histological, in vivo microdialysis and behavioral study.Brain Res. (1997) 770:115–
   PubMed Web of Science ®Google Scholar
• WADA Y, HASEGAWA H, OKUDA H, YAMAGUCHI N: Anticonvulsant effects of zonisamide and phenytoin on seizure activity of the feline visual cortex.Brain Dev. (1990) 12:206–210.
   PubMed Web of Science ®Google Scholar
• BRANDT C, POTSCHKA H, LOSCHER W, EBERT U: N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy. Neuroscience (2003) 118:727–740.
   PubMed Web of Science ®Google Scholar
• •An interesting article questioning the role of neuroprotection in antiepileptogenesis.
   Google Scholar
• DEDEURWAERDERE SM, CLAEYS P, RAEDT RA et al.: Levetiracetam has antiepileptogenic properties in GAERS. Epilepsia (2003) 44\(Suppl. 9):341.
   Google Scholar
• MCDONALD HW, BEHRENS MI, CHUNG C, BHATTACHARYYA T, CHOI DW: Susceptibility to apoptosis is enhanced in immature cortical neurons. Brain Res. (1997) 759:228–232.
   PubMed Web of Science ®Google Scholar
• MCDONALD JW, JOHNSTON MV: Physiological and pathophysiological roles of excitatory amino acids during central nervous system development.Brain Res. Rev (1990) 15:41–70.
   PubMed Web of Science ®Google Scholar
• INSEL TR, MILLER LP, GELHARD RE: The ontogeny of excitatory amino acid receptors in rat forebrain-I. N-methyl-D-aspartate and quisqualate receptors. Neuroscience (1990) 35:31–43.
   Google Scholar
• MCDONALD JW, JOHNSTON MV, YOUNG AB: Differential ontogenic development of three receptors comprising the NMDA receptor/channel complex in the rat hippocampus. Exp. Nemo]. (1990) 110:237–247.
   PubMed Web of Science ®Google Scholar
• MILLER LP, JOHNSON AE,GELHARD RE, INSEL TR: The ontogeny of excitatory amino acid receptors in the rat forebrain-II. Kainic acid receptors. Neuroscience (1990) 35:45–51.
   PubMed Web of Science ®Google Scholar
• LAZAREWICZ JW,PUKA-SUNDVALL M, GADAMSKI R, SANDBERG M, HAGBERG H: Differential effects of N-methyl-D-aspartate on Ca2+ homeostasis in developing and adult rat striatum: in vivo microdialysis approach. Int J Dev. Neurosci. (1995) 13:685–704.
   PubMedGoogle Scholar
• PAVONE A, CARDILE V: An in vitrostudy of new antiepileptic drugs and astrocytes. Epilepsia (2003)44\(Suppl. 10):34–39.
   Google Scholar
• •A systematic in vitro study describing the effects of AEDs on astrocytes.
   Google Scholar
• FOLLETT P, ROSENBERG PA,VOLPE JJ, JENSEN FE: NBQX attenuatesexcitotoxic injury in developing white matter. NeuroscL (2000) 20:9235–9241.
   PubMedGoogle Scholar
• HERNANDEZ TD: Preventing post-traumatic epilepsy after brain injury: weighting costs and benefits of anticonvulsant prophylaxis.Trends Pharmacol. ScL (1997) 18:59–62.
   PubMedGoogle Scholar
• ••A critical review about the effects of AEDson recovery process when administered after epileptogenic brain damaging in adults.
   Google Scholar
• ELLIOTT RC, MILES ME LOWENSTEIN DH: Overlapping microarray profiles of dentate gyrus gene expression during development- and epilepsy-associated neurogenesis and axon outgrowth. NeuroscL (2003) 23:2218–2227.
   PubMedGoogle Scholar
• LUKASIUK K, KONTULA L, PITKANEN A: cDNA profiling of epileptogenesis in the rat brain. Ear Neurosci (2003) 17(2):271–279.
   PubMedGoogle Scholar
• BITTIGAU P, SIFRINGER M, GENTZ K et al.: Antiepileptic drugs and apoptotic neurodegeneration in the developing brain.Proc. Natl. Acad. Sci. (2002) 99:15089-15094. Demonstrates surprising data about apoptosis-promoting effects of AEDs on immature brains.
   Google Scholar
• LOSCHER W: Current status and future directions in the pharmacotherapy of epilepsy. Trends Pharmacol Sci. (2002) 23:113–118.
   PubMed Web of Science ®Google Scholar
• KRUPP E, HEYNEN T, LI X, POST PM, WEISS SRB: Tolerance to the anticonvulsant effects of lamotrigine on amygdala kindled seizures: cross-tolerance to carbamazepine but not valporate or diazepam. Exp. Nemo]. (2000) 162:278–289.
   PubMedGoogle Scholar
• KELLY KM, KHARLAMOV A, HENTOSZ TM et al.: Photothrombotic brain infarction results in seizure activity in aging Fischer 344 and Sprague-Dawley rats. Epilepsy Res. (2001) 47(3):189–203.
   PubMed Web of Science ®Google Scholar
• BEZVENYUK Z, NISSINEN J, PITKANEN A. Photothrombotic brain infarction induced epileptogenesis in rats. Soc. Neurosci. Abst. (2003):533.15.
   Google Scholar
• KHARATISHVILI I, NISSINEN J, MCINTOSH TK, PITKANEN A: A rat model for head trauma induced epileptogenesis in humans.Epilepsia (2003) 44\(Suppl. 8):36.
   Google Scholar
• DAMBROSIO R, FAIRBANKS JP, FENDER JS, BORN DE, DOYLE DL, MILLER RV: Post-traumatic epilepsy following fluid percussion injury in the rat. Brain (2004) 127(Pt 2):304–14.
   PubMedGoogle Scholar
• MOHLER H, OKADA T: Benzodiazepine receptors: demonstration in the central nervous system. Science (1977) 198:849–851
   PubMed Web of Science ®Google Scholar
• MACDONALD RL, BARKER JL: Phenobarbital enhances GABA-mediated postsynaptic inhibition in cultured mammalian neurons. Trans. Am. Neurol Assoc. (1977) 102:139–140.
   PubMedGoogle Scholar
• BUTLER TC, WADDELL WJ: Metabolic conversion of primidone (IVIysoline) to Phenobarbital. Proc. Soc. Exp. Biol. Med. (1956) 93:544–546.
   PubMed Web of Science ®Google Scholar
• KAPETANOVIC IM, RUNDFELD C: D-23129: A new anticonvulsatn compound. CNS Drug Rev. (1996) 2:308–321.
   Google Scholar
• LIPPERT B, METCALF BW, JUNG MJ, CASARA P: 4-amino-hex-5-enoic acid, a selective catalytic inhibitor of 4-aminobutyric acid aminotransferase in mammalian brain. Eur. J.Biochem. (1977) 74:441–445.
   PubMedGoogle Scholar
• BRAESTRUP C, NIELSEN EB, SONNEWALD U et al.: R-N-14.4-bis(3-methy1-2-thienyl) but 3 3n 1 yll nipecotic acid binds which high affinity to the brain g-aminobutyric acid uptake carrier.Neurochem. (1990) 54:639–647.
   Google Scholar
• BLEAKMAN D, BALLYK BA,SCHOEPP DD et al.: Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: Stereospecitivity and selectivity), a novel anticonvulsant. Neuropharmacology (1996) 35:1689–1702
   Google Scholar
• COULTER DA, SOMBATI S, DELORENZO RI: Selective effects of topiramate on sustained repetitive firing and spontaneous bursting in cultured hippocampal neurons.Epilepsia (1993) 34\(Suppl. 2):S123.
   Google Scholar
• HARTY TP, ROGAWSKI MA: Felbamate block of recombinant N-methyl-D-aspartate receptors: selectivity for the NR2B subunit. Epilepsy Res. (2000) 39:47–55.
   PubMed Web of Science ®Google Scholar
• LANG D, WANG CM, COOPER B: Lamotrigine, phenytoin and carbamazepine interaction on the sodium current in N4TG1 mouse neuroblastoma cells.Pharmacol Exp. Ther. (1993) 266:29–35.
   Google Scholar
• PISANI A, STEFANI A, SINISCALCHI A, MERCURI NB, BERNARDI G, CALABRESI P: Electrophysiological actions of felbamate on striatal neurons. Br. PharmacoL (1995) 116:2053–2061.
   PubMedGoogle Scholar
• ROCK DM, MACDONALD RL, TAYLOR CP: Blocade of sustained repetive action potentials by zonisamide (AD 810,CI 912), a novel anticonvulsant. Epilepsy Res. (1989) 3:138–143.
   PubMed Web of Science ®Google Scholar
• MCLEAN MJ, SCHMUTZ M, WAMIL AW, OLPE H-R, PORTER C, FELDMANN KF: Oxcarbazepine: mechanisms of action. Epilepsia (1994) 35\(Suppl. 3):55–59.
   Google Scholar
• ZONA C, BARBAROSIE M,KAWASAKI H, AVOLI M: Effects induced by the anticonvulsant drug topiramate on voltage-gated sodium currents generated bycerebellar granule cells in tissue culture. Epilepsia (1996) 37\(Suppl. 5):524.
   Google Scholar
• MCLEAN MJ, MACDONALD RL: Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of actions potential of mouse central neurons in culture. Pharmacol Exp. Ther. (1986) 237:1001–1011.
   PubMed Web of Science ®Google Scholar
• SCHAUF CL: Zonisamide enhances slow sodium channel inactivation in Myxola. Brain Res. (1987) 413:185.
   PubMed Web of Science ®Google Scholar
• RUNDFELDT C: Characterization of the K+ channel opening effect of the anticonvulsant in neuronal cells. Epilepsy Res. (1999) 35:99–107.
   PubMed Web of Science ®Google Scholar
• HUGUENARD JR, PRINCE DA: A novel type of T-current underlies prolonged Ca2+ dependent burst firing in GABAergic neurons of rat reticular nucleus.Neurosci. (1992) 12:3804–3817.
   Google Scholar
• KITO M, MAEHARA M,WATANABE K: Mechanisms of T-type calcium channel blockade by zonisamide. Seizure (1996) 5:115–119.
   PubMed Web of Science ®Google Scholar
• DOOLEY DJ, MIESKE CA,BOROSKY SA: Inhibition of K(+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin.Neurosci. Lett. (2000) 280:107–110.
   PubMed Web of Science ®Google Scholar
• LEACH M, BAXTER M,CRITCHLEY M: Neurochemicaland behavioral aspects of lamotrigine. Epilepsia (1991) 32\(Suppl. 2):54–58.
   Google Scholar
• NILSSON M, HANSSON E, RONNBACK L: Interaction between valproate, glutamate, aspartate, and GABA with respect to uptake in astroglial primary cultures. Neurochem. Res. (1992) 17:327–332.
   PubMedGoogle Scholar